In addition, compared with the control group, TRIM38 deficiency markedly enhanced the HFD-induced glucose metabolic disorder, as evidenced by the higher glucose levels under fasting conditions and increased AUC of GTTs compared with the control group (Fig. 2C, D). This evidence concerns the gene TRIM38 and glucose metabolism disease.